APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Against Infectious Coryza for Poultry

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vaccine Against Infectious Coryza for Poultry Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchVaccine Against Infectious Coryza for Poultry Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Against Infectious Coryza for Poultry Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Vaccine Against Infectious Coryza for Poultry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Against Infectious Coryza for Poultry Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine Against Infectious Coryza for Poultry Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Vaccine Against Infectious Coryza for Poultry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vaccine Against Infectious Coryza for Poultry market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vaccine Against Infectious Coryza for Poultry market include HIPRA, MSD Animal Health, Qilu Animal Health, Ringpu, Shandong Huahong Biological, Shandong Lvdu Bio-Sciences, Wohua Biotech and Jilin Zhengye Biological Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vaccine Against Infectious Coryza for Poultry market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine Against Infectious Coryza for Poultry and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine Against Infectious Coryza for Poultry sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccine Against Infectious Coryza for Poultry market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccine Against Infectious Coryza for Poultry Segment by Company

HIPRA

MSD Animal Health

Qilu Animal Health

Ringpu

Shandong Huahong Biological

Shandong Lvdu Bio-Sciences

Wohua Biotech

Jilin Zhengye Biological Products

Vaccine Against Infectious Coryza for Poultry Segment by Type

Serotype A

Serotype A + Serotype B

Serotype A + Serotype B + Serotype C

Vaccine Against Infectious Coryza for Poultry Segment by Application

Government Tender

Market Sales

Vaccine Against Infectious Coryza for Poultry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vaccine Against Infectious Coryza for Poultry status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vaccine Against Infectious Coryza for Poultry market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vaccine Against Infectious Coryza for Poultry significant trends, drivers, influence factors in global and regions.

6. To analyze Vaccine Against Infectious Coryza for Poultry competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Against Infectious Coryza for Poultry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Against Infectious Coryza for Poultry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Against Infectious Coryza for Poultry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccine Against Infectious Coryza for Poultry market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccine Against Infectious Coryza for Poultry industry.

Chapter 3: Detailed analysis of Vaccine Against Infectious Coryza for Poultry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vaccine Against Infectious Coryza for Poultry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vaccine Against Infectious Coryza for Poultry in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vaccine Against Infectious Coryza for Poultry Industry Trends Table 2. Vaccine Against Infectious Coryza for Poultry Industry Drivers Table 3. Vaccine Against Infectious Coryza for Poultry Industry Opportunities and Challenges Table 4. Vaccine Against Infectious Coryza for Poultry Industry Restraints Table 5. Global Vaccine Against Infectious Coryza for Poultry Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vaccine Against Infectious Coryza for Poultry Revenue Share by Company (2021-2026) Table 7. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Company (k doses) & (2021-2026) Table 8. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Company (2021-2026) Table 9. Global Vaccine Against Infectious Coryza for Poultry Average Price (US$/k dose) of Company (2021-2026) Table 10. Global Vaccine Against Infectious Coryza for Poultry Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vaccine Against Infectious Coryza for Poultry Key Company Manufacturing Base & Headquarters Table 12. Global Vaccine Against Infectious Coryza for Poultry Company, Product Type & Application Table 13. Global Vaccine Against Infectious Coryza for Poultry Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vaccine Against Infectious Coryza for Poultry by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Serotype A Table 18. Significant Companies of Serotype A + Serotype B Table 19. Significant Companies of Serotype A + Serotype B + Serotype C Table 20. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Type 2021 VS 2025 VS 2032 (k doses) Table 21. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Type (2021-2026) & (k doses) Table 22. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Type (2027-2032) & (k doses) Table 23. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Type (2021-2026) Table 24. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Type (2027-2032) Table 25. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type (2021-2026) Table 29. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Government Tender Table 31. Significant Companies of Market Sales Table 32. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Application 2021 VS 2025 VS 2032 (k doses) Table 33. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Application (2021-2026) & (k doses) Table 34. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Application (2027-2032) & (k doses) Table 35. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Application (2021-2026) Table 36. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Application (2027-2032) Table 37. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application (2021-2026) Table 41. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application (2027-2032) Table 42. Global Vaccine Against Infectious Coryza for Poultry Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 43. Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2021-2026) & (k doses) Table 44. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Region (2021-2026) Table 45. Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2027-2032) & (k doses) Table 46. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Region (2027-2032) Table 47. Global Vaccine Against Infectious Coryza for Poultry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Region (2021-2026) Table 50. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Region (2027-2032) Table 52. Global Vaccine Against Infectious Coryza for Poultry Market Average Price (US$/k dose) by Region (2021-2026) Table 53. Global Vaccine Against Infectious Coryza for Poultry Market Average Price (US$/k dose) by Region (2027-2032) Table 54. Global Vaccine Against Infectious Coryza for Poultry Sales by Country: 2021 VS 2025 VS 2032 (k doses) Table 55. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 57. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2026) Table 58. Global Vaccine Against Infectious Coryza for Poultry Sales by Country (2027-2032) & (k doses) Table 59. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2027-2032) Table 60. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Vaccine Against Infectious Coryza for Poultry Sales Value Market Share by Country (2021-2026) Table 62. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Vaccine Against Infectious Coryza for Poultry Sales Value Market Share by Country (2027-2032) Table 64. HIPRA Company Information Table 65. HIPRA Business Overview Table 66. HIPRA Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 67. HIPRA Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 68. HIPRA Recent Development Table 69. MSD Animal Health Company Information Table 70. MSD Animal Health Business Overview Table 71. MSD Animal Health Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 72. MSD Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 73. MSD Animal Health Recent Development Table 74. Qilu Animal Health Company Information Table 75. Qilu Animal Health Business Overview Table 76. Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 77. Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 78. Qilu Animal Health Recent Development Table 79. Ringpu Company Information Table 80. Ringpu Business Overview Table 81. Ringpu Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 82. Ringpu Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 83. Ringpu Recent Development Table 84. Shandong Huahong Biological Company Information Table 85. Shandong Huahong Biological Business Overview Table 86. Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 87. Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 88. Shandong Huahong Biological Recent Development Table 89. Shandong Lvdu Bio-Sciences Company Information Table 90. Shandong Lvdu Bio-Sciences Business Overview Table 91. Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 92. Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 93. Shandong Lvdu Bio-Sciences Recent Development Table 94. Wohua Biotech Company Information Table 95. Wohua Biotech Business Overview Table 96. Wohua Biotech Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 97. Wohua Biotech Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 98. Wohua Biotech Recent Development Table 99. Jilin Zhengye Biological Products Company Information Table 100. Jilin Zhengye Biological Products Business Overview Table 101. Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Sales (k doses), Value (US$ Million), Price (US$/k dose) and Gross Margin (2021-2026) Table 102. Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 103. Jilin Zhengye Biological Products Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Vaccine Against Infectious Coryza for Poultry Distributors List Table 107. Vaccine Against Infectious Coryza for Poultry Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Vaccine Against Infectious Coryza for Poultry Product Image Figure 2. Global Vaccine Against Infectious Coryza for Poultry Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vaccine Against Infectious Coryza for Poultry Sales (2021-2032) & (k doses) Figure 5. Global Vaccine Against Infectious Coryza for Poultry Sales Average Price (US$/k dose) & (2021-2032) Figure 6. Global Vaccine Against Infectious Coryza for Poultry Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Serotype A Image Figure 10. Serotype A + Serotype B Image Figure 11. Serotype A + Serotype B + Serotype C Image Figure 12. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Type (2021 VS 2025 VS 2032) & (k doses) Figure 13. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Type (2021-2032) Figure 15. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type (2021-2032) Figure 18. Government Tender Image Figure 19. Market Sales Image Figure 20. Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Application (2021 VS 2025 VS 2032) & (k doses) Figure 21. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Application (2021-2032) Figure 23. Global Vaccine Against Infectious Coryza for Poultry Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application (2021-2032) Figure 26. Global Vaccine Against Infectious Coryza for Poultry Sales by Region: 2021 VS 2025 VS 2032 (k doses) Figure 27. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Vaccine Against Infectious Coryza for Poultry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032) & (US$ Million) Figure 31. North America Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032) & (US$ Million) Figure 37. South America Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Vaccine Against Infectious Coryza for Poultry Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Vaccine Against Infectious Coryza for Poultry Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Serotype A
  • Serotype A + Serotype B
  • Serotype A + Serotype B + Serotype C
Applications
  • Government Tender
  • Market Sales
Companies covered
  • HIPRA
  • MSD Animal Health
  • Qilu Animal Health
  • Ringpu
  • Shandong Huahong Biological
  • Shandong Lvdu Bio-Sciences
  • Wohua Biotech
  • Jilin Zhengye Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032)
  4. 1.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales Volume (2021-2032)
  5. 1.2.3 Global Vaccine Against Infectious Coryza for Poultry Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vaccine Against Infectious Coryza for Poultry Market Dynamics
  1. 2.1 Vaccine Against Infectious Coryza for Poultry Industry Trends
  2. 2.2 Vaccine Against Infectious Coryza for Poultry Industry Drivers
  3. 2.3 Vaccine Against Infectious Coryza for Poultry Industry Opportunities and Challenges
  4. 2.4 Vaccine Against Infectious Coryza for Poultry Industry Restraints
3 Vaccine Against Infectious Coryza for Poultry Market by Company
  1. 3.1 Global Vaccine Against Infectious Coryza for Poultry Company Revenue Ranking in 2025
  2. 3.2 Global Vaccine Against Infectious Coryza for Poultry Revenue by Company (2021-2026)
  3. 3.3 Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Company (2021-2026)
  4. 3.4 Global Vaccine Against Infectious Coryza for Poultry Average Price by Company (2021-2026)
  5. 3.5 Global Vaccine Against Infectious Coryza for Poultry Company Ranking (2024-2026)
  6. 3.6 Global Vaccine Against Infectious Coryza for Poultry Company Manufacturing Base and Headquarters
  7. 3.7 Global Vaccine Against Infectious Coryza for Poultry Company Product Type and Application
  8. 3.8 Global Vaccine Against Infectious Coryza for Poultry Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vaccine Against Infectious Coryza for Poultry Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vaccine Against Infectious Coryza for Poultry Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vaccine Against Infectious Coryza for Poultry Market by Type
  1. 4.1 Vaccine Against Infectious Coryza for Poultry Type Introduction
  2. 4.1.1 Serotype A
  3. 4.1.2 Serotype A + Serotype B
  4. 4.1.3 Serotype A + Serotype B + Serotype C
  5. 4.2 Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Type
  6. 4.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Type
  10. 4.3.1 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Type (2021-2032)
  12. 4.3.3 Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type (2021-2032)
5 Vaccine Against Infectious Coryza for Poultry Market by Application
  1. 5.1 Vaccine Against Infectious Coryza for Poultry Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Application
  5. 5.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Vaccine Against Infectious Coryza for Poultry Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Application
  9. 5.3.1 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Application (2021-2032)
  11. 5.3.3 Global Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application (2021-2032)
6 Vaccine Against Infectious Coryza for Poultry Regional Sales and Value Analysis
  1. 6.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2021-2032)
  3. 6.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Region: 2021-2026
  4. 6.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2027-2032)
  5. 6.3 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Region (2027-2032)
  9. 6.5 Global Vaccine Against Infectious Coryza for Poultry Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032)
  12. 6.6.2 North America Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032)
  15. 6.7.2 Europe Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032)
  21. 6.9.2 South America Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vaccine Against Infectious Coryza for Poultry Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vaccine Against Infectious Coryza for Poultry Sales Value Share by Country, 2025 VS 2032
7 Vaccine Against Infectious Coryza for Poultry Country-level Sales and Value Analysis
  1. 7.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2032)
  4. 7.3.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026)
  5. 7.3.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Country (2027-2032)
  6. 7.4 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vaccine Against Infectious Coryza for Poultry Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vaccine Against Infectious Coryza for Poultry Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vaccine Against Infectious Coryza for Poultry Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vaccine Against Infectious Coryza for Poultry Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 HIPRA
  2. 8.1.1 HIPRA Company Information
  3. 8.1.2 HIPRA Business Overview
  4. 8.1.3 HIPRA Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 HIPRA Vaccine Against Infectious Coryza for Poultry Product Portfolio
  6. 8.1.5 HIPRA Recent Developments
  7. 8.2 MSD Animal Health
  8. 8.2.1 MSD Animal Health Company Information
  9. 8.2.2 MSD Animal Health Business Overview
  10. 8.2.3 MSD Animal Health Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MSD Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio
  12. 8.2.5 MSD Animal Health Recent Developments
  13. 8.3 Qilu Animal Health
  14. 8.3.1 Qilu Animal Health Company Information
  15. 8.3.2 Qilu Animal Health Business Overview
  16. 8.3.3 Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio
  18. 8.3.5 Qilu Animal Health Recent Developments
  19. 8.4 Ringpu
  20. 8.4.1 Ringpu Company Information
  21. 8.4.2 Ringpu Business Overview
  22. 8.4.3 Ringpu Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ringpu Vaccine Against Infectious Coryza for Poultry Product Portfolio
  24. 8.4.5 Ringpu Recent Developments
  25. 8.5 Shandong Huahong Biological
  26. 8.5.1 Shandong Huahong Biological Company Information
  27. 8.5.2 Shandong Huahong Biological Business Overview
  28. 8.5.3 Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Product Portfolio
  30. 8.5.5 Shandong Huahong Biological Recent Developments
  31. 8.6 Shandong Lvdu Bio-Sciences
  32. 8.6.1 Shandong Lvdu Bio-Sciences Company Information
  33. 8.6.2 Shandong Lvdu Bio-Sciences Business Overview
  34. 8.6.3 Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Product Portfolio
  36. 8.6.5 Shandong Lvdu Bio-Sciences Recent Developments
  37. 8.7 Wohua Biotech
  38. 8.7.1 Wohua Biotech Company Information
  39. 8.7.2 Wohua Biotech Business Overview
  40. 8.7.3 Wohua Biotech Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Wohua Biotech Vaccine Against Infectious Coryza for Poultry Product Portfolio
  42. 8.7.5 Wohua Biotech Recent Developments
  43. 8.8 Jilin Zhengye Biological Products
  44. 8.8.1 Jilin Zhengye Biological Products Company Information
  45. 8.8.2 Jilin Zhengye Biological Products Business Overview
  46. 8.8.3 Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Product Portfolio
  48. 8.8.5 Jilin Zhengye Biological Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vaccine Against Infectious Coryza for Poultry Value Chain Analysis
  2. 9.1.1 Vaccine Against Infectious Coryza for Poultry Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vaccine Against Infectious Coryza for Poultry Sales Mode & Process
  6. 9.2 Vaccine Against Infectious Coryza for Poultry Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vaccine Against Infectious Coryza for Poultry Distributors
  9. 9.2.3 Vaccine Against Infectious Coryza for Poultry Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst